Free Trial
LON:BXP

Beximco Pharmaceuticals (BXP) Share Price, News & Analysis

Beximco Pharmaceuticals logo
GBX 35 -1.50 (-4.11%)
(As of 12/20/2024 10:57 AM ET)

About Beximco Pharmaceuticals Stock (LON:BXP)

Key Stats

Today's Range
35
37.70
50-Day Range
27.50
37.70
52-Week Range
19.33
42
Volume
8,902 shs
Average Volume
151,577 shs
Market Capitalization
£156.14 million
P/E Ratio
437.50
Dividend Yield
8.57%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies. It offers its products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. The company also exports its products. Beximco Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Dhaka, Bangladesh.

Receive BXP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Beximco Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

BXP Stock News Headlines

Beximco Pharma Share Chat (BXP)
The #1 Coin for November 2024
Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide…
Beximco Pharma Share Chat
Beximco Pharmaceuticals Ltd DR
See More Headlines

BXP Stock Analysis - Frequently Asked Questions

Beximco Pharmaceuticals' stock was trading at GBX 41.50 at the beginning of 2024. Since then, BXP shares have decreased by 15.7% and is now trading at GBX 35.
View the best growth stocks for 2024 here
.

Shares of BXP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Beximco Pharmaceuticals investors own include Advanced Micro Devices (AMD), Bank of America (BAC), Exxon Mobil (XOM), Salesforce (CRM), Chevron (CVX), Meta Platforms (META) and NIKE (NKE).

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
Trading
CIK
N/A
Fax
N/A
Employees
5,500
Year Founded
N/A

Profitability

Net Income
£5.33 billion
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£43.08 billion
Book Value
£104.17 per share

Miscellaneous

Free Float
N/A
Market Cap
£156.14 million
Optionable
Not Optionable
Beta
0.61
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (LON:BXP) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners